FRA

Cerro de Pasco Resources Closes a Subscription Receipt and Private Placement for a total of $2,845,000

Retrieved on: 
Tuesday, April 2, 2024
SOL, CDPR, FRA, Sale, Nature, CAD, Mine, Expiration date, AG, Ministry, Person, Qiwllaqucha, Acceleration, PB, News, National instrument, Easement, Mining, Offering, Supreme, Disclosure, Share (finance), Security (finance)

MONTRÉAL, April 02, 2024 (GLOBE NEWSWIRE) -- Cerro de Pasco Resources Inc. (CSE: CDPR) (OTCPK: GPPRF) (FRA: N8HP) (“CDPR” or the “Corporation”) is pleased to announce that further to its news release of March 22, 2024, it has closed a second tranche of its previously announced non-brokered private placement offering of subscription receipts to cover the fee payable in relation to the Legal Easement (the “Easement”). Upon publication of the Supreme Resolution granting the Easement, CDPR will pay SOL 3,647,402.44 or approximately CAD 1,350,000 to a specific bank account of Banco de la Nacion. The two-year Easement will provide CDPR with access to the surface areas corresponding to its El Metalurgista Concession and the Quiulacocha Tailings Project, enabling the Corporation to initiate its 40-hole drilling campaign.

Key Points: 
  • The Quiulacocha Tailings Storage Facility is comprised of processing residues that came from the Cerro de Pasco open pit and underground mine.
  • Under the second tranche, the Corporation has sold 10,150,000 subscription receipts of the Corporation (the “Subscription Receipts”) at a price of $0.10 per Subscription Receipt for aggregate gross proceeds of $1,015,000.
  • In total, the Corporation raised aggregate gross proceeds of $2,560,000 and issued 25,600,000 Subscription Receipts (the “Offering”).
  • Upon the satisfaction of the Release Conditions, 1) each Subscription Receipt will automatically be converted into a unit of the Corporation (“Unit”).

Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract

Retrieved on: 
Tuesday, April 2, 2024
Psilocybin, Psilocybe, Organization, Documentation, Learning, Certificate, Patient, Research, Good manufacturing practice, FRA, COA, International Council, Health Canada, GMP, Data collection, Quality, Harmonization, Ground substance, GACP, Water, Safety, ICH, MDMA, Good

Additionally, the Company has successfully completed the in-house encapsulation of psilocybin drug candidates in 5mg and 10mg dosage formats.

Key Points: 
  • Additionally, the Company has successfully completed the in-house encapsulation of psilocybin drug candidates in 5mg and 10mg dosage formats.
  • The third-party COA confirms critical information regarding potency, water content, microbial content, and heavy metal content, ensuring that the Natural Psilocybin Extract meets the predetermined specifications.
  • The completion of both extract validation and finished product testing aligns with Optimi's goal of advancing the drug candidate, marking significant progress toward its eventual release for human consumption.
  • “Obtaining successful results on the validation batches of psilocybin extract speaks to Optimi’s dedication to developing a repeatable, quality focused manufacturing process.

Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference

Retrieved on: 
Thursday, March 28, 2024
Tel Aviv University, EST, Conference, Research, Good manufacturing practice, FRA, Health Canada, GMP, Ground substance, Safety, API, Good, MDMA, Therapy, Psychedelic drug, Drug development, Pharmaceutical industry

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, proudly announces its role as a Presenting Sponsor at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference.

Key Points: 
  • VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, proudly announces its role as a Presenting Sponsor at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference.
  • The 4th Annual Psychedelic Therapeutics and Drug Development Conference convenes renowned researchers and esteemed leaders from academia, industry, non-profit organizations, and government sectors to explore the challenges and opportunities inherent in the research and development of psychedelic therapies for various health conditions with significant unmet needs.
  • “We believe this conference serves as an excellent platform for us to engage with key stakeholders, exchange ideas, and drive innovation in the field of psychedelic therapeutics,” he added.
  • Optimi delegates will be available at the conference to host networking sessions for those seeking more information about the company's GMP and API drug products.

Troilus Provides Operational Update

Retrieved on: 
Thursday, March 28, 2024
TLG, CAPEX, Exercise, Project, Gold, Copper, Publishing, FRA, Feasibility study, TSX

MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) (“Troilus” or the “Company”), provides an operational update related to the advancement of its gold-copper Troilus Project (“Troilus” or the “Project”), located in northcentral Quebec; one of the largest undeveloped gold equivalent deposits in North America.

Key Points: 
  • MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) (“Troilus” or the “Company”), provides an operational update related to the advancement of its gold-copper Troilus Project (“Troilus” or the “Project”), located in northcentral Quebec; one of the largest undeveloped gold equivalent deposits in North America.
  • The Feasibility Study for the Troilus Project is proceeding well, as the various components of the report approach finalization to create a cohesive picture of the potential future operation.
  • Justin Reid, CEO of Troilus, commented, “We see these exercises as a vote of confidence from some of our major shareholders.
  • These warrant exercises infuse cash into our treasury, strengthening our financial position as we progress Troilus towards a construction decision.”

PyroGenesis Schedules 2023 Fiscal Year Financial Results and Business Update Conference Call

Retrieved on: 
Thursday, March 28, 2024
GHG, Greenhouse, TSX, FRA, Pollution

MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, today announces that it plans to host a conference call at 10:00 AM Eastern Time on Tuesday April 2, 2024, to discuss the Company’s financial results for the fiscal year ended December 31, 2023, as well as the Company’s progress and other developments.

Key Points: 
  • MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, today announces that it plans to host a conference call at 10:00 AM Eastern Time on Tuesday April 2, 2024, to discuss the Company’s financial results for the fiscal year ended December 31, 2023, as well as the Company’s progress and other developments.
  • To access the conference call, please pre-register using this link .
  • Registrants will receive confirmation with dial-in details.

Metasphere Labs Begins Negotiations to Spearhead Integration for Pure Sky Registry LLC in Landmark Environmental Blockchain Initiative

Retrieved on: 
Wednesday, March 27, 2024
Ethereum, MOU, SOW, DAO, Elis James, Blockchain, FRA, BlackRock, Coinbase, Carbon, OTC, Cryptocurrency

Under this MOU, the Company is exploring a commission to integrate Pure Sky's pioneering carbon credit registry with blockchain technology, marking a significant advancement in environmental sustainability efforts.

Key Points: 
  • Under this MOU, the Company is exploring a commission to integrate Pure Sky's pioneering carbon credit registry with blockchain technology, marking a significant advancement in environmental sustainability efforts.
  • Pursuant to the MOU, the Company will also deliver a comprehensive statement of work (“SOW”) that will detail the scope, timeline, and responsibilities for the integration of the Pure Sky registry web application with the Pure Sky Decentralized Autonomous Organization (“DAO”) and carbon credit registry smart contracts.
  • Natasha Ingram CEO of Metasphere, remarked on the collaboration, “We are honored to explore partnering with Pure Sky, leading their blockchain integration efforts.
  • “This integration by Metasphere will revolutionize how we approach carbon credit transactions, enhancing our platform's accessibility and efficiency,” said Marty Seymour, Managing Director of Pure Sky.

White Gold Corp. Identifies Multiple Prospective IP Chargeability Anomalies on Two Large Multi-Element Porphyry Targets in Close Proximity to the Casino Copper-Gold Porphyry Deposit, Yukon, Canada

Retrieved on: 
Wednesday, March 27, 2024
Dawson Range, Lead, Copper, History, FRA, OTCQX, IP, RAB, Fracture, White Gold, Exploration, Silver, Anomaly, NW, Gold, Silver standard, Mitsubishi Materials, Bismuth, Propylitic alteration, WNW, M1, News, Textbook, Soil, Mining, Attention, Molybdenum, Zinc, 4N, Late Triassic, Tungsten, Late Cretaceous, ASD, Rare-earth element

All data collected thus far on these large early-stage targets continue to support a porphyry deposit model.

Key Points: 
  • All data collected thus far on these large early-stage targets continue to support a porphyry deposit model.
  • The new IP looked deeper than any previous geophysical surveys and demonstrates potential at depth beneath these large multi-element soil anomalies.
  • It’s now recommended to follow up with more IP survey lines to cover this large developing porphyry target.
  • The Bridget and Isaac targets represent large, early-stage, multi-element porphyry targets that have never been diamond drill tested.

ATHA Energy Announces 92 Energy Obtains Court Approval

Retrieved on: 
Wednesday, March 27, 2024
Uranium, Federal court, ASX, FRA, News, Acquisition, Scheme, Investment, GMZ, Athabasca

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (TSXV: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) is pleased to announce that the Federal Court of Australia (the “Court”) has made orders approving the previously announced Australian scheme (the “Scheme”) involving ATHA and 92 Energy Limited (ASX: 92E) (“92 Energy”).

Key Points: 
  • VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (TSXV: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA”) is pleased to announce that the Federal Court of Australia (the “Court”) has made orders approving the previously announced Australian scheme (the “Scheme”) involving ATHA and 92 Energy Limited (ASX: 92E) (“92 Energy”).
  • The Scheme was previously announced in the news releases of ATHA dated December 7, 2023, and January 25, 2024.
  • The Managing Director of 92 Energy, Siobhan Lancaster, said: “The merger with ATHA begins a new chapter of opportunity for 92 Energy shareholders.
  • 92 Energy has enjoyed significant exploration success since listing, culminating in its discovery of the GMZ, and I would like to thank the 92 Energy board, management, shareholders and advisors for their invaluable support and contributions.”
    Troy Boisjoli, Chief Executive Officer of ATHA, comments, “We are thrilled with the overwhelming level of support from 92 Energy’s shareholders in the previously announced vote to approve the transaction.

LEADING EDGE MATERIALS ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD THURSDAY, APRIL 25, 2024

Retrieved on: 
Wednesday, March 27, 2024
Remuneration, Computershare, 14th Floor Records, Notice, Corporation, Euroclear, CDS, FRA, Bank statement

The record date for the Meeting is March 19, 2024.

Key Points: 
  • The record date for the Meeting is March 19, 2024.
  • The Notice of Meeting, the accompanying Management Proxy Circular and related meeting materials are available under the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at https://leadingedgematerials.com/ .
  • The information in this section is of significance to Shareholders who hold their securities (“Euroclear Registered Securities“) through Euroclear Sweden AB, which securities trade on the Nasdaq First North.
  • Shareholders who hold Euroclear Registered Securities are not registered holders of voting securities for the purposes of voting at the Meeting.

PyroGenesis Announces Acquisition of Intellectual Property Rights Related to the PUREVAPᵀᴹ Nano Silicon Reactor and Nano-Silicon Development

Retrieved on: 
Tuesday, March 26, 2024
PCT, GHG, FRA, 0 A.D. (video game), Pollution, Silicon, TSX, ARC, Patent, Greenhouse

The PUREVAP™ NSiR is a proprietary process, originally designed and developed by PyroGenesis on behalf of HPQ Nano Silicon Powders Inc. (“HPQ Nano”), a wholly-owned subsidiary of HPQ Silicon, that can use different purities of silicon (Si) as feedstock to make a wide range of spherical silicon nano- and micro-powders and wires, for potential use across various applications including as a potential replacement metal in lithium-ion batteries.

Key Points: 
  • The PUREVAP™ NSiR is a proprietary process, originally designed and developed by PyroGenesis on behalf of HPQ Nano Silicon Powders Inc. (“HPQ Nano”), a wholly-owned subsidiary of HPQ Silicon, that can use different purities of silicon (Si) as feedstock to make a wide range of spherical silicon nano- and micro-powders and wires, for potential use across various applications including as a potential replacement metal in lithium-ion batteries.
  • Under the terms of a 2020 Development and Purchase Agreement between PyroGenesis and HPQ Nano, all rights in the PUREVAP NSiR process (including any intellectual property rights) were assigned to HPQ Nano on condition that should HPQ Nano choose not to commercialize the technology, PyroGenesis would have the option to have the ownership of this technology revert back to it at no additional cost.
  • “Nano silicon is still in its infancy, and so is the understanding of its usefulness.
  • Reacquiring the intellectual property related to the PUREVAP NSiR allows us to continue to explore the full spectrum of possibilities for this metal,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis.